1 Recombinant Erythropoietin Drugs Market Overview 1.1 Product Overview and Scope of Recombinant Erythropoietin Drugs 1.2 Recombinant Erythropoietin Drugs Segment by Type 1.2.1 Global Recombinant Erythropoietin Drugs Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 rhEPO 1.2.3 Erythropoiesis-Stimulating Agents (ESA) 1.3 Recombinant Erythropoietin Drugs Segment by Application 1.3.1 Global Recombinant Erythropoietin Drugs Sales Comparison by Application: (2021-2027) 1.3.2 Chronic Kidney Disease 1.3.3 Cancer Related Anemia 1.3.4 Others 1.4 Global Recombinant Erythropoietin Drugs Market Size Estimates and Forecasts 1.4.1 Global Recombinant Erythropoietin Drugs Revenue 2016-2027 1.4.2 Global Recombinant Erythropoietin Drugs Sales 2016-2027 1.4.3 Recombinant Erythropoietin Drugs Market Size by Region: 2016 Versus 2021 Versus 2027 2 Recombinant Erythropoietin Drugs Market Competition by Manufacturers 2.1 Global Recombinant Erythropoietin Drugs Sales Market Share by Manufacturers (2016-2021) 2.2 Global Recombinant Erythropoietin Drugs Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Recombinant Erythropoietin Drugs Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Recombinant Erythropoietin Drugs Manufacturing Sites, Area Served, Product Type 2.5 Recombinant Erythropoietin Drugs Market Competitive Situation and Trends 2.5.1 Recombinant Erythropoietin Drugs Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Recombinant Erythropoietin Drugs Players Market Share by Revenue 2.5.3 Global Recombinant Erythropoietin Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Recombinant Erythropoietin Drugs Retrospective Market Scenario by Region 3.1 Global Recombinant Erythropoietin Drugs Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Recombinant Erythropoietin Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Recombinant Erythropoietin Drugs Market Facts & Figures by Country 3.3.1 North America Recombinant Erythropoietin Drugs Sales by Country 3.3.2 North America Recombinant Erythropoietin Drugs Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Recombinant Erythropoietin Drugs Market Facts & Figures by Country 3.4.1 Europe Recombinant Erythropoietin Drugs Sales by Country 3.4.2 Europe Recombinant Erythropoietin Drugs Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Recombinant Erythropoietin Drugs Market Facts & Figures by Region 3.5.1 Asia Pacific Recombinant Erythropoietin Drugs Sales by Region 3.5.2 Asia Pacific Recombinant Erythropoietin Drugs Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Recombinant Erythropoietin Drugs Market Facts & Figures by Country 3.6.1 Latin America Recombinant Erythropoietin Drugs Sales by Country 3.6.2 Latin America Recombinant Erythropoietin Drugs Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Recombinant Erythropoietin Drugs Market Facts & Figures by Country 3.7.1 Middle East and Africa Recombinant Erythropoietin Drugs Sales by Country 3.7.2 Middle East and Africa Recombinant Erythropoietin Drugs Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Recombinant Erythropoietin Drugs Historic Market Analysis by Type 4.1 Global Recombinant Erythropoietin Drugs Sales Market Share by Type (2016-2021) 4.2 Global Recombinant Erythropoietin Drugs Revenue Market Share by Type (2016-2021) 4.3 Global Recombinant Erythropoietin Drugs Price by Type (2016-2021) 5 Global Recombinant Erythropoietin Drugs Historic Market Analysis by Application 5.1 Global Recombinant Erythropoietin Drugs Sales Market Share by Application (2016-2021) 5.2 Global Recombinant Erythropoietin Drugs Revenue Market Share by Application (2016-2021) 5.3 Global Recombinant Erythropoietin Drugs Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Amgen 6.1.1 Amgen Corporation Information 6.1.2 Amgen Description and Business Overview 6.1.3 Amgen Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Amgen Recombinant Erythropoietin Drugs Product Portfolio 6.1.5 Amgen Recent Developments/Updates 6.2 Johnson & Johnson 6.2.1 Johnson & Johnson Corporation Information 6.2.2 Johnson & Johnson Description and Business Overview 6.2.3 Johnson & Johnson Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Johnson & Johnson Recombinant Erythropoietin Drugs Product Portfolio 6.2.5 Johnson & Johnson Recent Developments/Updates 6.3 Kyowa Hakko Kirin 6.3.1 Kyowa Hakko Kirin Corporation Information 6.3.2 Kyowa Hakko Kirin Description and Business Overview 6.3.3 Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Product Portfolio 6.3.5 Kyowa Hakko Kirin Recent Developments/Updates 6.4 Roche 6.4.1 Roche Corporation Information 6.4.2 Roche Description and Business Overview 6.4.3 Roche Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Roche Recombinant Erythropoietin Drugs Product Portfolio 6.4.5 Roche Recent Developments/Updates 6.5 3SBio Group 6.5.1 3SBio Group Corporation Information 6.5.2 3SBio Group Description and Business Overview 6.5.3 3SBio Group Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 6.5.4 3SBio Group Recombinant Erythropoietin Drugs Product Portfolio 6.5.5 3SBio Group Recent Developments/Updates 6.6 Celltrion, Inc 6.6.1 Celltrion, Inc Corporation Information 6.6.2 Celltrion, Inc Description and Business Overview 6.6.3 Celltrion, Inc Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Celltrion, Inc Recombinant Erythropoietin Drugs Product Portfolio 6.6.5 Celltrion, Inc Recent Developments/Updates 6.7 Teva Pharmaceutical Industries Ltd 6.6.1 Teva Pharmaceutical Industries Ltd Corporation Information 6.6.2 Teva Pharmaceutical Industries Ltd Description and Business Overview 6.6.3 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Product Portfolio 6.7.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates 6.8 F. Hoffmann-La Roche Ltd 6.8.1 F. Hoffmann-La Roche Ltd Corporation Information 6.8.2 F. Hoffmann-La Roche Ltd Description and Business Overview 6.8.3 F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 6.8.4 F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Product Portfolio 6.8.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates 6.9 LG Life Sciences Ltd 6.9.1 LG Life Sciences Ltd Corporation Information 6.9.2 LG Life Sciences Ltd Description and Business Overview 6.9.3 LG Life Sciences Ltd Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 6.9.4 LG Life Sciences Ltd Recombinant Erythropoietin Drugs Product Portfolio 6.9.5 LG Life Sciences Ltd Recent Developments/Updates 6.10 Biocon Limited 6.10.1 Biocon Limited Corporation Information 6.10.2 Biocon Limited Description and Business Overview 6.10.3 Biocon Limited Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Biocon Limited Recombinant Erythropoietin Drugs Product Portfolio 6.10.5 Biocon Limited Recent Developments/Updates 6.11 Intas Pharmaceuticals Ltd 6.11.1 Intas Pharmaceuticals Ltd Corporation Information 6.11.2 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Description and Business Overview 6.11.3 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Product Portfolio 6.11.5 Intas Pharmaceuticals Ltd Recent Developments/Updates 6.12 Sun Pharmaceutical Industries Ltd 6.12.1 Sun Pharmaceutical Industries Ltd Corporation Information 6.12.2 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Description and Business Overview 6.12.3 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 6.12.4 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Product Portfolio 6.12.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates 6.13 Dr. Reddy's Laboratories Ltd 6.13.1 Dr. Reddy's Laboratories Ltd Corporation Information 6.13.2 Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Description and Business Overview 6.13.3 Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 6.13.4 Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Product Portfolio 6.13.5 Dr. Reddy's Laboratories Ltd Recent Developments/Updates 7 Recombinant Erythropoietin Drugs Manufacturing Cost Analysis 7.1 Recombinant Erythropoietin Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Recombinant Erythropoietin Drugs 7.4 Recombinant Erythropoietin Drugs Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Recombinant Erythropoietin Drugs Distributors List 8.3 Recombinant Erythropoietin Drugs Customers 9 Recombinant Erythropoietin Drugs Market Dynamics 9.1 Recombinant Erythropoietin Drugs Industry Trends 9.2 Recombinant Erythropoietin Drugs Growth Drivers 9.3 Recombinant Erythropoietin Drugs Market Challenges 9.4 Recombinant Erythropoietin Drugs Market Restraints 10 Global Market Forecast 10.1 Recombinant Erythropoietin Drugs Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Recombinant Erythropoietin Drugs by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Recombinant Erythropoietin Drugs by Type (2022-2027) 10.2 Recombinant Erythropoietin Drugs Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Recombinant Erythropoietin Drugs by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Recombinant Erythropoietin Drugs by Application (2022-2027) 10.3 Recombinant Erythropoietin Drugs Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Recombinant Erythropoietin Drugs by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Recombinant Erythropoietin Drugs by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Recombinant Erythropoietin Drugs Sales (KG) Growth Rate Comparison by Type (2021-2027) Table 2. Global Recombinant Erythropoietin Drugs Sales (KG) Comparison by Application (2021-2027) Table 3. Global Recombinant Erythropoietin Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Recombinant Erythropoietin Drugs Covered in This Study Table 5. Global Recombinant Erythropoietin Drugs Sales (KG) of Key Manufacturers (2016-2021) Table 6. Global Recombinant Erythropoietin Drugs Sales Market Share by Manufacturers (2016-2021) Table 7. Global Recombinant Erythropoietin Drugs Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Recombinant Erythropoietin Drugs Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Recombinant Erythropoietin Drugs Average Price (USD/g) of Key Manufacturers (2016-2021) Table 10. Manufacturers Recombinant Erythropoietin Drugs Manufacturing Sites and Area Served Table 11. Manufacturers Recombinant Erythropoietin Drugs Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Recombinant Erythropoietin Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Erythropoietin Drugs as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Recombinant Erythropoietin Drugs Sales by Region (2016-2021) & (KG) Table 16. Global Recombinant Erythropoietin Drugs Sales Market Share by Region (2016-2021) Table 17. Global Recombinant Erythropoietin Drugs Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Recombinant Erythropoietin Drugs Sales by Country (2016-2021) & (KG) Table 19. North America Recombinant Erythropoietin Drugs Sales Market Share by Country (2016-2021) Table 20. North America Recombinant Erythropoietin Drugs Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Recombinant Erythropoietin Drugs Revenue Market Share by Country (2016-2021) Table 22. Europe Recombinant Erythropoietin Drugs Sales by Country (2016-2021) & (KG) Table 23. Europe Recombinant Erythropoietin Drugs Sales Market Share by Country (2016-2021) Table 24. Europe Recombinant Erythropoietin Drugs Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Recombinant Erythropoietin Drugs Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Recombinant Erythropoietin Drugs Sales by Region (2016-2021) & (KG) Table 27. Asia Pacific Recombinant Erythropoietin Drugs Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Recombinant Erythropoietin Drugs Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Recombinant Erythropoietin Drugs Revenue Market Share by Region (2016-2021) Table 30. Latin America Recombinant Erythropoietin Drugs Sales by Country (2016-2021) & (KG) Table 31. Latin America Recombinant Erythropoietin Drugs Sales Market Share by Country (2016-2021) Table 32. Latin America Recombinant Erythropoietin Drugs Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Recombinant Erythropoietin Drugs Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Recombinant Erythropoietin Drugs Sales by Country (2016-2021) & (KG) Table 35. Middle East and Africa Recombinant Erythropoietin Drugs Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Recombinant Erythropoietin Drugs Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Recombinant Erythropoietin Drugs Revenue Market Share by Country (2016-2021) Table 38. Global Recombinant Erythropoietin Drugs Sales (KG) by Type (2016-2021) Table 39. Global Recombinant Erythropoietin Drugs Sales Market Share by Type (2016-2021) Table 40. Global Recombinant Erythropoietin Drugs Revenue (Million US$) by Type (2016-2021) Table 41. Global Recombinant Erythropoietin Drugs Revenue Share by Type (2016-2021) Table 42. Global Recombinant Erythropoietin Drugs Price (USD/g) by Type (2016-2021) Table 43. Global Recombinant Erythropoietin Drugs Sales (KG) by Application (2016-2021) Table 44. Global Recombinant Erythropoietin Drugs Sales Market Share by Application (2016-2021) Table 45. Global Recombinant Erythropoietin Drugs Revenue (Million US$) by Application (2016-2021) Table 46. Global Recombinant Erythropoietin Drugs Revenue Share by Application (2016-2021) Table 47. Global Recombinant Erythropoietin Drugs Price (USD/g) by Application (2016-2021) Table 48. Amgen Corporation Information Table 49. Amgen Description and Business Overview Table 50. Amgen Recombinant Erythropoietin Drugs Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 51. Amgen Recombinant Erythropoietin Drugs Product Table 52. Amgen Recent Developments/Updates Table 53. Johnson & Johnson Corporation Information Table 54. Johnson & Johnson Description and Business Overview Table 55. Johnson & Johnson Recombinant Erythropoietin Drugs Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 56. Johnson & Johnson Recombinant Erythropoietin Drugs Product Table 57. Johnson & Johnson Recent Developments/Updates Table 58. Kyowa Hakko Kirin Corporation Information Table 59. Kyowa Hakko Kirin Description and Business Overview Table 60. Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 61. Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Product Table 62. Kyowa Hakko Kirin Recent Developments/Updates Table 63. Roche Corporation Information Table 64. Roche Description and Business Overview Table 65. Roche Recombinant Erythropoietin Drugs Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 66. Roche Recombinant Erythropoietin Drugs Product Table 67. Roche Recent Developments/Updates Table 68. 3SBio Group Corporation Information Table 69. 3SBio Group Description and Business Overview Table 70. 3SBio Group Recombinant Erythropoietin Drugs Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 71. 3SBio Group Recombinant Erythropoietin Drugs Product Table 72. 3SBio Group Recent Developments/Updates Table 73. Celltrion, Inc Corporation Information Table 74. Celltrion, Inc Description and Business Overview Table 75. Celltrion, Inc Recombinant Erythropoietin Drugs Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 76. Celltrion, Inc Recombinant Erythropoietin Drugs Product Table 77. Celltrion, Inc Recent Developments/Updates Table 78. Teva Pharmaceutical Industries Ltd Corporation Information Table 79. Teva Pharmaceutical Industries Ltd Description and Business Overview Table 80. Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 81. Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Product Table 82. Teva Pharmaceutical Industries Ltd Recent Developments/Updates Table 83. F. Hoffmann-La Roche Ltd Corporation Information Table 84. F. Hoffmann-La Roche Ltd Description and Business Overview Table 85. F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 86. F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Product Table 87. F. Hoffmann-La Roche Ltd Recent Developments/Updates Table 88. LG Life Sciences Ltd Corporation Information Table 89. LG Life Sciences Ltd Description and Business Overview Table 90. LG Life Sciences Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 91. LG Life Sciences Ltd Recombinant Erythropoietin Drugs Product Table 92. LG Life Sciences Ltd Recent Developments/Updates Table 93. Biocon Limited Corporation Information Table 94. Biocon Limited Description and Business Overview Table 95. Biocon Limited Recombinant Erythropoietin Drugs Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 96. Biocon Limited Recombinant Erythropoietin Drugs Product Table 97. Biocon Limited Recent Developments/Updates Table 98. Intas Pharmaceuticals Ltd Corporation Information Table 99. Intas Pharmaceuticals Ltd Description and Business Overview Table 100. Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 101. Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Product Table 102. Intas Pharmaceuticals Ltd Recent Developments/Updates Table 103. Sun Pharmaceutical Industries Ltd Corporation Information Table 104. Sun Pharmaceutical Industries Ltd Description and Business Overview Table 105. Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 106. Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Product Table 107. Sun Pharmaceutical Industries Ltd Recent Developments/Updates Table 108. Dr. Reddy's Laboratories Ltd Corporation Information Table 109. Dr. Reddy's Laboratories Ltd Description and Business Overview Table 110. Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 111. Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Product Table 112. Dr. Reddy's Laboratories Ltd Recent Developments/Updates Table 113. Production Base and Market Concentration Rate of Raw Material Table 114. Key Suppliers of Raw Materials Table 115. Recombinant Erythropoietin Drugs Distributors List Table 116. Recombinant Erythropoietin Drugs Customers List Table 117. Recombinant Erythropoietin Drugs Market Trends Table 118. Recombinant Erythropoietin Drugs Growth Drivers Table 119. Recombinant Erythropoietin Drugs Market Challenges Table 120. Recombinant Erythropoietin Drugs Market Restraints Table 121. Global Recombinant Erythropoietin Drugs Sales Forecast by Type (2022-2027) & (KG) Table 122. Global Recombinant Erythropoietin Drugs Sales Market Share Forecast by Type (2022-2027) Table 123. Global Recombinant Erythropoietin Drugs Revenue Forecast by Type (2022-2027) & (US$ Million) Table 124. Global Recombinant Erythropoietin Drugs Revenue Market Share Forecast by Type (2022-2027) Table 125. Global Recombinant Erythropoietin Drugs Sales Forecast by Application (2022-2027) & (KG) Table 126. Global Recombinant Erythropoietin Drugs Sales Market Share Forecast by Application (2022-2027) Table 127. Global Recombinant Erythropoietin Drugs Revenue Forecast by Application (2022-2027) & (US$ Million) Table 128. Global Recombinant Erythropoietin Drugs Revenue Market Share Forecast by Application (2022-2027) Table 129. Global Recombinant Erythropoietin Drugs Sales Forecast by Region (2022-2027) & (KG) Table 130. Global Recombinant Erythropoietin Drugs Sales Market Share Forecast by Region (2022-2027) Table 131. Global Recombinant Erythropoietin Drugs Revenue Forecast by Region (2022-2027) & (US$ Million) Table 132. Global Recombinant Erythropoietin Drugs Revenue Market Share Forecast by Region (2022-2027) Table 133. Research Programs/Design for This Report Table 134. Key Data Information from Secondary Sources Table 135. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Recombinant Erythropoietin Drugs Figure 2. Global Recombinant Erythropoietin Drugs Market Share by Type in 2020 & 2027 Figure 3. rhEPO Product Picture Figure 4. Erythropoiesis-Stimulating Agents (ESA) Product Picture Figure 5. Global Recombinant Erythropoietin Drugs Market Share by Application in 2020 & 2027 Figure 6. Chronic Kidney Disease Figure 7. Cancer Related Anemia Figure 8. Others Figure 9. Global Recombinant Erythropoietin Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Recombinant Erythropoietin Drugs Market Size 2016-2027 (US$ Million) Figure 11. Global Recombinant Erythropoietin Drugs Sales 2016-2027 (KG) Figure 12. Global Recombinant Erythropoietin Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 13. Recombinant Erythropoietin Drugs Sales Share by Manufacturers in 2020 Figure 14. Global Recombinant Erythropoietin Drugs Revenue Share by Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Recombinant Erythropoietin Drugs Players: Market Share by Revenue in 2020 Figure 16. Recombinant Erythropoietin Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 17. Global Recombinant Erythropoietin Drugs Sales Market Share by Region (2016-2021) Figure 18. Global Recombinant Erythropoietin Drugs Sales Market Share by Region in 2020 Figure 19. Global Recombinant Erythropoietin Drugs Revenue Market Share by Region (2016-2021) Figure 20. Global Recombinant Erythropoietin Drugs Revenue Market Share by Region in 2020 Figure 21. U.S. Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Canada Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Germany Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. France Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. U.K. Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Italy Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Russia Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. China Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Japan Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. South Korea Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. India Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Australia Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Taiwan Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Indonesia Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Thailand Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Malaysia Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Philippines Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Vietnam Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Mexico Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Brazil Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Argentina Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Turkey Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Saudi Arabia Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. U.A.E Recombinant Erythropoietin Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Sales Market Share of Recombinant Erythropoietin Drugs by Type (2016-2021) Figure 46. Sales Market Share of Recombinant Erythropoietin Drugs by Application (2016-2021) Figure 47. Sales Market Share of Recombinant Erythropoietin Drugs by Application in 2020 Figure 48. Revenue Share of Recombinant Erythropoietin Drugs by Application (2016-2021) Figure 49. Revenue Share of Recombinant Erythropoietin Drugs by Application in 2020 Figure 50. Manufacturing Cost Structure of Recombinant Erythropoietin Drugs Figure 51. Manufacturing Process Analysis of Recombinant Erythropoietin Drugs Figure 52. Recombinant Erythropoietin Drugs Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

1 Recombinant Erythropoietin Drugs Market Overview 1.1 Product Overview and Scope of Recombinant Erythropoietin Drugs 1.2 Recombinant Erythropoietin Drugs Segment by Type 1.2.1 Global Recombinant Erythropoietin Drugs Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 rhEPO 1.2.3 Erythropoiesis-Stimulating Agents (ESA) 1.3 Recombinant Erythropoietin Drugs Segment by Application 1.3.1 Global Recombinant Erythropoietin Drugs Sales Comparison by Application: (2021-2027) 1.3.2 Chronic Kidney Disease 1.3.3 Cancer Related Anemia 1.3.4 Others 1.4 Global Recombinant Erythropoietin Drugs Market Size Estimates and Forecasts 1.4.1 Global Recombinant Erythropoietin Drugs Revenue 2016-2027 1.4.2 Global Recombinant Erythropoietin Drugs Sales 2016-2027 1.4.3 Recombinant Erythropoietin Drugs Market Size by Region: 2016 Versus 2021 Versus 2027 2 Recombinant Erythropoietin Drugs Market Competition by Manufacturers 2.1 Global Recombinant Erythropoietin Drugs Sales Market Share by Manufacturers (2016-2021) 2.2 Global Recombinant Erythropoietin Drugs Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Recombinant Erythropoietin Drugs Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Recombinant Erythropoietin Drugs Manufacturing Sites, Area Served, Product Type 2.5 Recombinant Erythropoietin Drugs Market Competitive Situation and Trends 2.5.1 Recombinant Erythropoietin Drugs Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Recombinant Erythropoietin Drugs Players Market Share by Revenue 2.5.3 Global Recombinant Erythropoietin Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Recombinant Erythropoietin Drugs Retrospective Market Scenario by Region 3.1 Global Recombinant Erythropoietin Drugs Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Recombinant Erythropoietin Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Recombinant Erythropoietin Drugs Market Facts & Figures by Country 3.3.1 North America Recombinant Erythropoietin Drugs Sales by Country 3.3.2 North America Recombinant Erythropoietin Drugs Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Recombinant Erythropoietin Drugs Market Facts & Figures by Country 3.4.1 Europe Recombinant Erythropoietin Drugs Sales by Country 3.4.2 Europe Recombinant Erythropoietin Drugs Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Recombinant Erythropoietin Drugs Market Facts & Figures by Region 3.5.1 Asia Pacific Recombinant Erythropoietin Drugs Sales by Region 3.5.2 Asia Pacific Recombinant Erythropoietin Drugs Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Recombinant Erythropoietin Drugs Market Facts & Figures by Country 3.6.1 Latin America Recombinant Erythropoietin Drugs Sales by Country 3.6.2 Latin America Recombinant Erythropoietin Drugs Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Recombinant Erythropoietin Drugs Market Facts & Figures by Country 3.7.1 Middle East and Africa Recombinant Erythropoietin Drugs Sales by Country 3.7.2 Middle East and Africa Recombinant Erythropoietin Drugs Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Recombinant Erythropoietin Drugs Historic Market Analysis by Type 4.1 Global Recombinant Erythropoietin Drugs Sales Market Share by Type (2016-2021) 4.2 Global Recombinant Erythropoietin Drugs Revenue Market Share by Type (2016-2021) 4.3 Global Recombinant Erythropoietin Drugs Price by Type (2016-2021) 5 Global Recombinant Erythropoietin Drugs Historic Market Analysis by Application 5.1 Global Recombinant Erythropoietin Drugs Sales Market Share by Application (2016-2021) 5.2 Global Recombinant Erythropoietin Drugs Revenue Market Share by Application (2016-2021) 5.3 Global Recombinant Erythropoietin Drugs Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Amgen 6.1.1 Amgen Corporation Information 6.1.2 Amgen Description and Business Overview 6.1.3 Amgen Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Amgen Recombinant Erythropoietin Drugs Product Portfolio 6.1.5 Amgen Recent Developments/Updates 6.2 Johnson & Johnson 6.2.1 Johnson & Johnson Corporation Information 6.2.2 Johnson & Johnson Description and Business Overview 6.2.3 Johnson & Johnson Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Johnson & Johnson Recombinant Erythropoietin Drugs Product Portfolio 6.2.5 Johnson & Johnson Recent Developments/Updates 6.3 Kyowa Hakko Kirin 6.3.1 Kyowa Hakko Kirin Corporation Information 6.3.2 Kyowa Hakko Kirin Description and Business Overview 6.3.3 Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Product Portfolio 6.3.5 Kyowa Hakko Kirin Recent Developments/Updates 6.4 Roche 6.4.1 Roche Corporation Information 6.4.2 Roche Description and Business Overview 6.4.3 Roche Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Roche Recombinant Erythropoietin Drugs Product Portfolio 6.4.5 Roche Recent Developments/Updates 6.5 3SBio Group 6.5.1 3SBio Group Corporation Information 6.5.2 3SBio Group Description and Business Overview 6.5.3 3SBio Group Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 6.5.4 3SBio Group Recombinant Erythropoietin Drugs Product Portfolio 6.5.5 3SBio Group Recent Developments/Updates 6.6 Celltrion, Inc 6.6.1 Celltrion, Inc Corporation Information 6.6.2 Celltrion, Inc Description and Business Overview 6.6.3 Celltrion, Inc Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Celltrion, Inc Recombinant Erythropoietin Drugs Product Portfolio 6.6.5 Celltrion, Inc Recent Developments/Updates 6.7 Teva Pharmaceutical Industries Ltd 6.6.1 Teva Pharmaceutical Industries Ltd Corporation Information 6.6.2 Teva Pharmaceutical Industries Ltd Description and Business Overview 6.6.3 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Product Portfolio 6.7.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates 6.8 F. Hoffmann-La Roche Ltd 6.8.1 F. Hoffmann-La Roche Ltd Corporation Information 6.8.2 F. Hoffmann-La Roche Ltd Description and Business Overview 6.8.3 F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 6.8.4 F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Product Portfolio 6.8.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates 6.9 LG Life Sciences Ltd 6.9.1 LG Life Sciences Ltd Corporation Information 6.9.2 LG Life Sciences Ltd Description and Business Overview 6.9.3 LG Life Sciences Ltd Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 6.9.4 LG Life Sciences Ltd Recombinant Erythropoietin Drugs Product Portfolio 6.9.5 LG Life Sciences Ltd Recent Developments/Updates 6.10 Biocon Limited 6.10.1 Biocon Limited Corporation Information 6.10.2 Biocon Limited Description and Business Overview 6.10.3 Biocon Limited Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Biocon Limited Recombinant Erythropoietin Drugs Product Portfolio 6.10.5 Biocon Limited Recent Developments/Updates 6.11 Intas Pharmaceuticals Ltd 6.11.1 Intas Pharmaceuticals Ltd Corporation Information 6.11.2 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Description and Business Overview 6.11.3 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Product Portfolio 6.11.5 Intas Pharmaceuticals Ltd Recent Developments/Updates 6.12 Sun Pharmaceutical Industries Ltd 6.12.1 Sun Pharmaceutical Industries Ltd Corporation Information 6.12.2 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Description and Business Overview 6.12.3 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 6.12.4 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Product Portfolio 6.12.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates 6.13 Dr. Reddy's Laboratories Ltd 6.13.1 Dr. Reddy's Laboratories Ltd Corporation Information 6.13.2 Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Description and Business Overview 6.13.3 Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Sales, Revenue and Gross Margin (2016-2021) 6.13.4 Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Product Portfolio 6.13.5 Dr. Reddy's Laboratories Ltd Recent Developments/Updates 7 Recombinant Erythropoietin Drugs Manufacturing Cost Analysis 7.1 Recombinant Erythropoietin Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Recombinant Erythropoietin Drugs 7.4 Recombinant Erythropoietin Drugs Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Recombinant Erythropoietin Drugs Distributors List 8.3 Recombinant Erythropoietin Drugs Customers 9 Recombinant Erythropoietin Drugs Market Dynamics 9.1 Recombinant Erythropoietin Drugs Industry Trends 9.2 Recombinant Erythropoietin Drugs Growth Drivers 9.3 Recombinant Erythropoietin Drugs Market Challenges 9.4 Recombinant Erythropoietin Drugs Market Restraints 10 Global Market Forecast 10.1 Recombinant Erythropoietin Drugs Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Recombinant Erythropoietin Drugs by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Recombinant Erythropoietin Drugs by Type (2022-2027) 10.2 Recombinant Erythropoietin Drugs Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Recombinant Erythropoietin Drugs by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Recombinant Erythropoietin Drugs by Application (2022-2027) 10.3 Recombinant Erythropoietin Drugs Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Recombinant Erythropoietin Drugs by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Recombinant Erythropoietin Drugs by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer